Insulin was delivered ‘open‐loop’ at predetermined basal rates and 15‐fold higher prandial rates and infused via an intravenous insulin pump worn in a shoulder bag by seven participants with T1D over a trial period of 1‐5 days. This evidence concerns the gene INS and type 1 diabetes mellitus.